Schedule 13G Amendment No. 5

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 5)*

 

 

 

 

Marvell Technology Group Ltd.

(Name of Issuer)

 

 

Common shares, par value $0.002 per share

(Title of Class of Securities)

 

 

G 5876H105

(CUSIP Number)

 

 

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

Page 1 of 6


CUSIP No. G 5876H105

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

Dr. Sehat Sutardja

   
  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x

(b)  ¨

   
  3.  

SEC Use Only

 

   
  4.  

Citizenship or Place of Organization

 

United States

   

 

Number of  

Shares  

Beneficially  

Owned by  

Each  

Reporting  

Person  

With  

 

 

  5.    Sole Voting Power

 

       0 shares

 

  6.    Shared Voting Power

 

       66,903,343 shares*

 

  7.    Sole Dispositive Power

 

       0 shares

 

  8.    Shared Dispositive Power

 

       66,903,343 shares*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

66,903,343 shares*

   
10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

 

 

 

¨

11.  

Percent of Class Represented by Amount in Row (9)

 

10.8%

   
12.  

Type of Reporting Person (See Instructions)

 

IN

   

 

* Shares may be deemed beneficially owned by Dr. Sehat Sutardja and include (i) 18,253,334 shares owned by The Sutardja Family Partners, a California family limited partnership, of which Dr. Sehat Sutardja and Ms. Dai are the general partners and share voting and dispositive power, and (ii) 1,672,692 shares issuable pursuant to stock options exercisable on March 1, 2009, held by Dr. Sehat Sutardja. Dr. Sehat Sutardja and Ms. Dai are married to each other and live in California, a community property state. As such, each may be deemed to be the beneficial owner (with voting and investment power) with respect to all of the outstanding shares held.

 

Page 2 of 6


CUSIP No. G 5876H105

 

  1.  

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

 

Weili Dai

   
  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x

(b)  ¨

   
  3.  

SEC Use Only

 

   
  4.  

Citizenship or Place of Organization

 

United States

   

 

Number of  

Shares  

Beneficially  

Owned by  

Each  

Reporting  

Person  

With  

 

 

  5.    Sole Voting Power

 

       0 shares

 

  6.    Shared Voting Power

 

       66,903,343 shares*

 

  7.    Sole Dispositive Power

 

       0 shares

 

  8.    Shared Dispositive Power

 

       66,903,343 shares*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

66,903,343 shares*

   
10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

 

 

 

¨

11.  

Percent of Class Represented by Amount in Row (9)

 

10.8%

   
12.  

Type of Reporting Person (See Instructions)

 

IN

   

 

* Shares may be deemed beneficially owned by Ms. Dai and include (i) 18,253,334 shares owned by The Sutardja Family Partners, a California family limited partnership, of which Dr. Sehat Sutardja and Ms. Dai are the general partners and share voting and dispositive power, and (ii) 1,672,692 shares issuable pursuant to stock options exercisable on March 1, 2009, held by Dr. Sehat Sutardja. Dr. Sehat Sutardja and Ms. Dai are married to each other and live in California, a community property state. As such, each may be deemed to be the beneficial owner (with voting and investment power) with respect to all of the outstanding shares held.

 

Page 3 of 6


Item 1.

 

  (a) Name of Issuer

Marvell Technology Group Ltd.

 

  (b) Address of Issuer’s Principal Executive Offices

Marvell Technology Group Ltd.

Canon’s Court

22 Victoria Street

Hamilton HM 12

Bermuda

 

Item 2.

 

  (a) Name of Person Filing

Dr. Sehat Sutardja

 

  (b) Address of Principal Business Office or, if none, Residence

Marvell Semiconductor, Inc.

5488 Marvell Lane

Santa Clara, CA 95054

 

  (c) Citizenship

United States

 

  (d) Title of Class of Securities

Common shares, par value $0.002 per share

 

  (e) CUSIP Number

G 5876H105

 

  (a) Name of Person Filing

Weili Dai

 

  (b) Address of Principal Business Office or, if none, Residence

Marvell Semiconductor, Inc.

5488 Marvell Lane

Santa Clara, CA 95054

 

  (c) Citizenship

United States

 

  (d) Title of Class of Securities

Common shares, par value $0.002 per share

 

  (e) CUSIP Number

G 5876H105

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

 

Page 4 of 6


Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1*.

 

  (a) Amount beneficially owned:

66,903,343 shares**

 

  (b) Percent of class:

10.8%

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote

  0 shares

 

  (ii) Shared power to vote or to direct the vote

  66,903,343 shares*

 

  (iii) Sole power to dispose or to direct the disposition of

  0 shares

 

  (iv) Shared power to dispose or to direct the disposition of

  66,903,343 shares*

 

* Dr. Sehat Sutardja and Ms. Dai are married to each other and live in California, a community property state. As such, each may be deemed to be the beneficial owner (with voting and investment power) with respect to all of the outstanding shares held.

 

** Shares may be deemed beneficially owned by each of the Reporting Persons and include (i) 18,253,334 shares owned by The Sutardja Family Partners, a California family limited partnership, of which Dr. Sehat Sutardja and Ms. Dai are the general partners and share voting and dispositive power, and (ii) 1,672,692 shares issuable pursuant to stock options exercisable on or March 1, 2009, held by Dr. Sehat Sutardja.

 

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

Not applicable.

 

Item 9. Notice of Dissolution of Group

Not applicable.

 

Item 10. Certification

Not applicable.

 

Page 5 of 6


Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 13, 2009
Date
/s/ Dr. Sehat Sutardja
Signature
Dr. Sehat Sutardja
Name/Title
February 13, 2009
Date
/s/ Weili Dai
Signature
Weili Dai
Name/Title

 

Page 6 of 6


Exhibit Index

 

Exhibit

  

Description

99.1    Agreement of Joint Filing dated as of February 13, 2009.